187532-84-9Relevant academic research and scientific papers
Compounds for the treatment of metabolic disorders
-
Page/Page column 72; 73; 82, (2016/03/12)
Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
High-speed microwave assisted synthesis of SEA0400 - A selective inhibitor of the Na+/Ca2+ exchanger
De La Cruz, Gemma Guedes,Groschner, Klaus,Oliver Kappe,Glasnov, Toma N.
supporting information; experimental part, p. 3731 - 3734 (2012/09/22)
An efficient and rapid five-step synthesis of SEA0400, a selective Na +/Ca2+ exchanger (NCX) inhibitor, using controlled microwave heating is reported. In addition, a novel three-step route omitting the key Baeyer-Villiger oxidation/
Novel aryloxy azolyl chalcones with potent activity against Mycobacterium tuberculosis H37Rv
Marrapu, Vijay K.,Chaturvedi, Vinita,Singh, Shubhra,Singh, Shyam,Sinha, Sudhir,Bhandari, Kalpana
experimental part, p. 4302 - 4310 (2011/11/13)
A series of twenty seven novel aryloxy azolyl chalcones were synthesized and evaluated in vitro for the growth inhibition of Mycobacterium tuberculosis H37Rv. Ten compounds from this series exhibited good activity with MIC in the range of 3.12-0.78 μg/mL
Compounds for the treatment of metabolic disorders
-
, (2008/06/13)
Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
